Medtech Archives - Page 71 of 127 - Boston Life Sciences Times

Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Trial

June 30, 2026

FDA Approves Viridian Therapeutics’ Lumvoa for Thyroid Eye Disease

June 29, 2026

PharmaEssentia Launches FDA-Approved BESREMi Pen for Polycythemia Vera

June 26, 2026

THIS WEEK'S STORIES

ASP Isotopes’ Noble Africa to Merge With ENDRA Life Sciences in Deal Backed by $50 Million Financing

June 25, 2026

Cellares Joins FDA’s Inaugural Manufacturing PreCheck Pilot

June 30, 2026

Insulet Appoints Jonathan Mazelsky to Board of Directors

June 25, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Exact Imaging Expands U.S. Sales Team Amid Growing Demand for Prostate Imaging System

Thubrikar Aortic Valve Partners With MAC’s MEDICAL Group to Expand European Trial

University Health Selects Philips Platform to Standardize Patient Monitoring

MedX Health Launches SkinSecure Platform for Noninvasive Skin Research

University of Miami Health System Deploys 3D Medical Imaging Platform for Patient Consultations

Most Read

Valerio Therapeutics Signs Binding Offer to Acquire Etherna Immunotherapies

MindWalk Files European Patent for AI Drug Discovery Data Architecture

INTENT Biologics Receives FDA Breakthrough Therapy Designation for Diabetic Foot Ulcer Treatment

Form Health Begins Prescribing Through Medicare GLP-1 Bridge Program

EDITOR PICKS